SIGA Technologies, Inc. (SIGA) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
SIGA Technologies, Inc.
Address
31 East 62nd Street
New York City, NY 10065
United States of America (the)
Phone
212 672 9100
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
49
First IPO Date
September 10, 1997
Key Executives
| Name | Title | Pay | Year Born |
| Diem Nguyen | Chief Executive Officer & Director | 1.39M | 1972 |
| Lawrence Miller | General Counsel & Corporate Secretary | 1.04M | 1968 |
| Dennis E. Hruby | Executive Vice President & Chief Scientific Officer | 1.31M | 1952 |
| Daniel J. Luckshire | Executive Vice President, Chief Financial Officer & Secretary | 1.32M | 1971 |
| Herb Vloedman | Senior Vice President & Chief Information Officer | 0 | N/A |
| Suzanne Harnett | Senior Vice President of Corporate Affairs & Investor Relations | 0 | N/A |
Description
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
